Form D · Biotechnology
Oncopia Therapeutics, LLC
Malvern, PA · CIK 0001726626
Offering snapshot reported Jan 2, 2019 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2019 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Nov 7, 2018 | Initial | $4,370,000 | No comparison | 8 | SEC filing |
| Jan 5, 2018 | Initial | $2,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-329406
Source: Form D, filed Jan 2, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Mel Sorensen | Director |
| Shaomeng Wang | Director, Executive |
| Brian Wood | Executive |
| Eric Qun Zhao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 West Liberty Boulevard Suite 110
Malvern, PA, 19355
Malvern, PA, 19355